We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| scPharmaceuticals Inc | NASDAQ:SCPH | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.08 | 1.72% | 4.74 | 4.71 | 4.74 | 4.85 | 4.64 | 4.76 | 88,389 | 19:43:36 |
From May 2019 to May 2024
scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs, today announced that John Tucker, president and chief executive officer, will present at the 9th Annual SVB Leerink Global Healthcare Conference at 10:00 a.m. ET on Tuesday, February 25, 2020, at the Lotte New York Palace Hotel in New York, NY.
Investors interested in arranging a meeting with the Company’s management during this conference should contact the conference coordinator.
About scPharmaceuticals
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company’s lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200220005113/en/
Katherine Taudvin scPharmaceuticals Inc., 781-301-6706 ktaudvin@scpharma.com
Christopher F. Brinzey Westwicke, an ICR Company, 339-970-2843 chris.brinzey@westwicke.com
1 Year scPharmaceuticals Chart |
1 Month scPharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
